Armata Pharmaceuticals, Inc.
ARMP
$5.57
-$0.42-7.01%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.68M | -16.30M | -6.53M | 2.60M | -5.48M |
| Total Depreciation and Amortization | 370.00K | 366.00K | 377.00K | 380.00K | 313.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.19M | 10.71M | -229.00K | -12.10M | -2.76M |
| Change in Net Operating Assets | 1.81M | -2.00M | -1.20M | 1.19M | -935.00K |
| Cash from Operations | -4.30M | -7.21M | -7.58M | -7.93M | -8.86M |
| Capital Expenditure | -242.00K | -149.00K | -99.00K | 77.00K | -340.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -242.00K | -149.00K | -99.00K | 77.00K | -340.00K |
| Total Debt Issued | 15.00M | 0.00 | 10.00M | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -32.00K | 0.00 | -14.00K | 0.00 | -61.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.97M | 0.00 | 9.99M | 0.00 | -61.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.43M | -7.36M | 2.31M | -7.85M | -9.26M |